Arachis hypogaea
(peanut) is a potential source of bioactive compounds including flavonols and proanthocyanidins, which have gained particular interest of metabolic engineering owing to their significance in the growth, development and defense responses in plants. To gain insight of proanthocyanidins and flavonols production in
A. hypogaea
,
Leucoanthocyanidin reductase (AhLAR)
and
Flavonol synthase (AhFLS)
enzymes responsible for their production, have been structurally, transcriptionally and functionally characterized. Structural and functional analysis of putative protein sequence of
AhFLS
indicated two functional motifs 2OG-FeII_Oxy and DIOX_N
,
while six functional motifs belonging to the families of NAD-dependent dehydratase, 3,
β hydroxysteroid dehydrogenase
and NmrA-like family were observed in case of
AhLAR.
Promoter sequence analysis unraveled several promoter elements related to the development regulation, environmental stress responses and hormonal signaling. Furthermore, the expression analysis of
AhFLS
and
AhLAR
and accumulation pattern analysis of proanthocyanidins and flavonols in three selected cultivars of
A. hypogaea
under saline environment confirmed their role against salinity in genotype-dependent and stress level-dependent manner. Correlation studies revealed that AhFLS and AhLAR expression is not directly dependent on the antioxidant enzymes activity, biochemical and growth parameters but higher Pearson r value depicted some level of dependency. This detailed study of AhLAR and AhFLS can assist in the metabolic engineering of flavonoid biosynthetic pathway to produce stress tolerant varieties and production of proanthocyanidins and flavonols at an industrial scale.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.